Reuters reports that the U.S. District Attorney’s office for the Southern District of New York is investigating Pfizer Inc for quality issues at its Meridian Medical Technologies site, where EpiPens are manufactured.
Mylan NV, which markets Epipens, has previously recalled thousands of EpiPens due to reports that they were failing to activate. Meanwhile, in 2017, Meridian received a warning from the Food and Drug Administration for failure to investigate dangerous product failures.
The investigation is still ongoing.
About the Previous Epipen Recall
Epipens are devices designed to inject an emergency dose of epinephrine in the case of a severe allergic reaction.
In 2017, Mylan announced a recall of 13 Epipen lots, distributed between December 17, 2015 and July 1, 2016.
Consumers whose EpiPens are not working properly or are causing adverse reactions are encouraged to submit a report to the FDA’s MedWatch program.
Hurt By a Defective EpiPen? Contact Thomas J. Henry
Defective and faulty medical devices have the potential to cause long-lasting and permanent damage in patients seeking treatment for their injuries and illnesses. In some cases, defective medical devices have caused fatal injuries, causing devastation to the victim’s family. At Thomas J. Henry, we will fight vigorously on you and your family’s behalf. We have the legal and financial resources necessary to properly develop your case and take on the large pharmaceutical and medical device manufacturers.